A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

P48.09 Anlotinib Plus Etoposide and Carboplatin as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer: A Single Arm Phase II Trial

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.879 ◽

2021 ◽

Vol 16 (3) ◽

pp. S503

Author(s):

B. Han ◽

W. Zhang ◽

B. Zhang ◽

Y. Chen ◽

Y. Zhang ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Extensive Stage ◽

Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients

Anticancer Research ◽

10.21873/anticanres.12661 ◽

2018 ◽

Vol 38 (6) ◽

pp. 3779-3784 ◽

Cited By ~ 1

Author(s):

HIROAKI TAKEOKA ◽

KAZUHIKO YAMADA ◽

YOSHIKO NAITO ◽

NORIKAZU MATSUO ◽

HIDENOBU ISHII ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

A Novel Phase Ii Trial of Ipilimumab, Carboplatin and Etoposide (Ice) for the First Line Treatment of Extensive Stage Small Cell Lung Cancer (Sclc)

Annals of Oncology ◽

10.1093/annonc/mdu355.15 ◽

2014 ◽

Vol 25 ◽

pp. iv516

Author(s):

C. Ottensmeier ◽

I. Galea ◽

N. Cross ◽

T. Maishman ◽

D. Hamid ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Extensive Stage ◽

P-457 Docetaxel/gemcitabine vs. cisplatin/gemcitabine followed bydocetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Results of a randomised phase II trial

Lung Cancer ◽

10.1016/s0169-5002(05)80950-x ◽

2005 ◽

Vol 49 ◽

pp. S236-S237

Author(s):

D. Binder ◽

H. Schweisfurth ◽

C. Grah ◽

C. Schäper ◽

B. Temmesfeld-Wollbrück ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Pemetrexed and carboplatin, an active option in first-line treatment of elderly patients with advanced non-small cell lung cancer (NSCLC): A phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2013.01.008 ◽

2013 ◽

Vol 80 (2) ◽

pp. 185-190 ◽

Cited By ~ 22

Author(s):

Radj Gervais ◽

Gilles Robinet ◽

Christelle Clément-Duchêne ◽

Fabrice Denis ◽

Claude El Kouri ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Docetaxel and gefitinib in the first-line treatment of elderly patients (≥70) with advanced non-small cell lung cancer (ANSCLC): Results of phase II trial

10.1200/jco.2005.23.16_suppl.7155 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7155-7155 ◽

Cited By ~ 5

Author(s):

G. Bepler ◽

C. C. Williams ◽

A. Chiappori ◽

S. J. Antonia ◽

E. B. Haura ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Preliminary results of a randomized phase II trial of pemetrexed (P) + carboplatin (Cb) ± enzastaurin (ENZ) versus docetaxel (D) + Cb as first-line treatment of patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

10.1200/jco.2008.26.15_suppl.8061 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 8061-8061 ◽

Cited By ~ 2

Author(s):

D. M. Kocs ◽

R. N. Raju ◽

M. A. Socinski ◽

T. E. Stinchcombe ◽

S. R. Rousey ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Randomized Phase Ii ◽

Preliminary results of a randomized phase II trial of first-line treatment of gemcitabine (G) versus erlotinib (E) versus gemcitabine and erlotinib (GE) in patients 70 years or older with advanced non-small cell lung cancer (NSCLC).

10.1200/jco.2010.28.15_suppl.7576 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 7576-7576 ◽

Cited By ~ 1

Author(s):

T. Stinchcombe ◽

D. S. Bradford ◽

C. B. Lee ◽

D. T. Moore ◽

K. M. Bakri ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Randomized Phase Ii ◽

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e3181fd42eb ◽

2010 ◽

Vol 5 (12) ◽

pp. 1963-1969 ◽

Cited By ~ 25

Author(s):

Mark A. Socinski ◽

Robert N. Raju ◽

Thomas Stinchcombe ◽

Darren M. Kocs ◽

Linda S. Couch ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Randomized Phase Ii ◽

Sequential cisplatin–gemcitabine–docetaxel vs docetaxel–gemcitabine in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): Interim results of an ongoing phase II trial

10.1200/jco.2004.22.90140.7113 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7113-7113 ◽

Cited By ~ 1

Author(s):

D. Binder ◽

T. Beinert ◽

H. Schweisfurth ◽

C. Grah ◽

B. Temmesfeld-Wollbrück ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Line Treatment ◽

Small Cell Lung ◽

First Line ◽

Ongoing Phase ◽